EPA vs DHA When Buying an Omega 3

EPA and DHA are both long-chain omega-3 fatty acids found in fish oil and algae-based supplements, but they are not interchangeable. Understanding what each one does, and what the research does and does not support, helps you make a more informed choice at the pharmacy shelf.

What EPA and DHA Actually Are

Omega-3 fatty acids come in several forms. The three most discussed are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). ALA is found mainly in plant foods such as flaxseed and walnuts. EPA and DHA are found primarily in fatty fish, seafood, and algae. According to the NIH Office of Dietary Supplements (ODS), the body can convert ALA into EPA and DHA, but only in very small amounts, so dietary or supplemental sources of EPA and DHA remain important for most people.

What Each Fatty Acid Does in the Body

The NIH ODS describes three main physiological roles for omega-3 fatty acids as a group.

• Cell membrane structure. EPA and DHA serve as structural components of the phospholipids that form cell membranes throughout the body. DHA is especially concentrated in the retina, brain, and sperm. This structural role is supported by strong evidence.
• Energy source. Like other fats, omega-3s provide a source of energy for the body.
• Eicosanoid precursors. EPA and DHA act as precursors to eicosanoids, which are signaling molecules involved in cardiovascular, pulmonary, immune, and endocrine system function.

These are physiological roles, not disease claims. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the FDA.

EPA vs DHA: Where They Differ

While EPA and DHA share the roles above, their concentrations differ by tissue. DHA makes up a large proportion of the fatty acids in the brain and retina, which is why it is often highlighted in products marketed for eye health or early childhood nutrition. EPA, on the other hand, is more prominently involved in the production of eicosanoids that influence inflammatory pathways, which is why it tends to appear in products marketed for joint or cardiovascular support.

Neither claim should be taken at face value without checking the evidence grade behind it.

What the Evidence Actually Shows

The NIH ODS grades the evidence for omega-3 supplements across several health areas. Here is an honest summary.

Triglycerides

Long-chain omega-3 supplements, meaning EPA and DHA combined, lower elevated serum triglyceride levels. The NIH ODS rates this evidence as moderate. This is the most consistently supported benefit of fish oil supplementation.

Cardiovascular Events

The evidence that omega-3 supplements reduce the risk of most cardiovascular events in the general population is rated as limited by the NIH ODS. Results across trials have been mixed, and this is an active area of research.

Infant Neurodevelopment and Vision

DHA supplementation during pregnancy or infancy is often marketed for brain and eye development. The NIH ODS rates the evidence that omega-3 supplementation improves infant neurodevelopment or visual development as insufficient at this time.

Cognitive Decline and Dementia

The evidence that omega-3 supplements prevent cognitive decline, dementia, or Alzheimer disease is rated as insufficient by the NIH ODS.

Age-Related Macular Degeneration

Despite DHA's concentration in the retina, the evidence that omega-3 supplements slow the progression of age-related macular degeneration is rated as insufficient.

Rheumatoid Arthritis

The evidence that omega-3 supplements relieve symptoms of rheumatoid arthritis is rated as limited.

Grading evidence honestly matters. A physiological role for a nutrient does not automatically mean a supplement dose will produce a measurable clinical outcome.

Intake Reference Values

According to the NIH ODS and the National Academies of Sciences, Engineering, and Medicine, no Recommended Dietary Allowance (RDA) has been set for EPA or DHA specifically. The Institute of Medicine set an Adequate Intake (AI) for ALA, not for EPA or DHA, because data were insufficient to establish an Estimated Average Requirement. The AI for ALA is 1.6 grams per day for adult men and 1.1 grams per day for adult women ages 19 to 50. No Tolerable Upper Intake Level has been established for any omega-3 fatty acid.

The FDA specifies that dietary supplement labels should not recommend a daily intake of EPA and DHA higher than 2 grams combined from supplements. Because no personal intake target exists for EPA or DHA in the reference values, consult a clinician or pharmacist to determine a dose that makes sense for your individual situation.

Safety and Side Effects

Omega-3s from food and supplements are generally regarded as safe. Side effects from supplements are usually mild and may include unpleasant taste, bad breath, bad-smelling sweat, headache, heartburn, nausea, stomach discomfort, or diarrhea. Taking capsules with meals and choosing enteric-coated products can reduce some of these effects for many people.

At high doses, roughly 900 mg per day of EPA plus 600 mg per day of DHA or more taken for several weeks, omega-3s may suppress inflammatory immune responses and reduce immune function. Prescription high-dose omega-3 products used to lower triglycerides are drug-strength doses and should be taken only under medical supervision.

Medication Interactions

Talk to a doctor or pharmacist before combining omega-3 supplements with any medication. Because omega-3s can reduce platelet aggregation and prolong bleeding time, combining them with anticoagulant or antiplatelet medications such as warfarin, aspirin, or clopidogrel, or with other blood-thinning herbs or supplements, may theoretically increase bleeding risk. Clinical trials have generally shown that prolonged bleeding time did not exceed normal limits or cause clinically significant bleeding, but periodic monitoring is still advisable.

How to Read the Label

When comparing products, look past the total fish oil milligrams on the front of the bottle and go straight to the Supplement Facts panel. The numbers that matter are the individual EPA and DHA milligrams per serving. A 1,000 mg fish oil softgel might contain only 300 mg of combined EPA and DHA, with the rest being other fats. Products vary widely in their EPA to DHA ratios, so matching the ratio to your reason for supplementing, and confirming that choice with a clinician, is more useful than choosing by total oil weight alone.

Bottom Line

EPA and DHA play distinct but overlapping roles in the body. DHA is heavily concentrated in the brain and retina, while EPA is more central to eicosanoid signaling pathways. The most consistently supported benefit of combined EPA and DHA supplementation is lowering elevated triglycerides, rated as moderate evidence by the NIH ODS. Evidence for other commonly marketed benefits ranges from limited to insufficient. Use the Supplement Facts panel to compare actual EPA and DHA content, stay within the FDA's 2 gram daily supplement guidance, and speak with a clinician or pharmacist before starting a supplement, especially if you take any medications.